MOBKL1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.139600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.495600E-01
Normal-vs-Stage2
3.960400E-01
Normal-vs-Stage3
2.215400E-01
Normal-vs-Stage4
8.272000E-01
Stage1-vs-Stage2
4.050600E-01
Stage1-vs-Stage3
1.665820E-01
Stage1-vs-Stage4
1.363430E-01
Stage2-vs-Stage3
6.709800E-02
Stage2-vs-Stage4
1.485630E-01
Stage3-vs-Stage4
1.004600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.022000E-01
Normal-vs-AfricanAmerican
8.594600E-01
Normal-vs-Asian
2.094000E-01
Caucasian-vs-AfricanAmerican
2.870600E-01
Caucasian-vs-Asian
5.439400E-01
AfricanAmerican-vs-Asian
2.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.080000E-01
Normal-vs-Female
3.460400E-01
Male-vs-Female
7.660200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.256600E-01
Normal-vs-Age(41-60Yrs)
6.498400E-01
Normal-vs-Age(61-80Yrs)
2.117600E-01
Normal-vs-Age(81-100Yrs)
1.330210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.778600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.274200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.728400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.374340E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.800000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.765770E-01
Normal-vs-Daily Drinker
1.987600E-01
Normal-vs-Weekly Drinker
2.534400E-01
Normal-vs-Occasional Drinker
5.342600E-01
Normal-vs-Social Drinker
4.214400E-01
Non Drinker-vs-Daily Drinker
7.058200E-01
Non Drinker-vs-Weekly Drinker
8.464800E-01
Non Drinker-vs-Occasional Drinker
3.668600E-01
Non Drinker-vs-Social Drinker
4.645000E-01
Daily Drinker-vs-Weekly Drinker
9.053400E-01
Daily Drinker-vs-Occasional Drinker
2.931200E-01
Daily Drinker-vs-Social Drinker
3.603200E-01
Weekly Drinker-vs-Occasional Drinker
4.157200E-01
Weekly Drinker-vs-Social Drinker
4.761800E-01
Occasional Drinker-vs-Social Drinker
8.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.025000E-01
Normal-vs-Grade 2
5.209900E-02
Normal-vs-Grade 3
3.800200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.000600E-03
Grade 1-vs-Grade 3
1.963820E-03
Grade 1-vs-Grade 4
4.025000E-01
Grade 2-vs-Grade 3
2.583800E-01
Grade 2-vs-Grade 4
5.209900E-02
Grade 3-vs-Grade 4
3.800200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.338600E-01
Normal-vs-NonDiabetic
1.832400E-01
Diabetic-vs-NonDiabetic
4.425600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.074400E-01
Normal-vs-NoPancreatitis
2.521800E-01
Pancreatitis-vs-NoPancreatitis
8.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.449600E-01
Normal-vs-N1
3.901600E-01
N0-vs-N1
2.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.463400E-01
Normal-vs-TP53-NonMutant
2.317000E-01
TP53-Mutant-vs-TP53-NonMutant
1.179930E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
